Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer

Immune-checkpoint inhibitors (ICI) have transformed oncological therapy. Up to 20% of all non-small cell lung cancers (NSCLCs) show durable responses upon treatment with ICI, however, robust markers to predict therapy response are missing. Here we show that blood platelets interact with lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinterleitner, Clemens, Strähle, Jasmin, Malenke, Elke, Hinterleitner, Martina, Henning, Melanie, Seehawer, Marco, Bilich, Tatjana, Heitmann, Jonas, Lutz, Martina, Mattern, Sven, Scheuermann, Sophia, Horger, Marius, Maurer, Stefanie, Walz, Juliane, Fend, Falko, Handgretinger, Rupert, Seitz, Christian, Weigelin, Bettina, Singer, Stephan, Salih, Helmut, Borst, Oliver, Kopp, Hans-Georg, Zender, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636618/
https://www.ncbi.nlm.nih.gov/pubmed/34853305
http://dx.doi.org/10.1038/s41467-021-27303-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636618/
https://www.ncbi.nlm.nih.gov/pubmed/34853305
http://dx.doi.org/10.1038/s41467-021-27303-7

Ejemplares similares